RABEPRAZOLE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Rabeprazole Sodium patents expire, and what generic alternatives are available?
Rabeprazole Sodium is a drug marketed by Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma, Dr Reddys, Lannett Co Inc, Lupin Ltd, Mylan, Rubicon, Teva Pharms Usa, and Torrent. and is included in ten NDAs.
The generic ingredient in RABEPRAZOLE SODIUM is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rabeprazole Sodium
A generic version of RABEPRAZOLE SODIUM was approved as rabeprazole sodium by DR REDDYS on November 8th, 2013.
Summary for RABEPRAZOLE SODIUM
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 21 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Clinical Trials: | 45 |
Patent Applications: | 1,140 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RABEPRAZOLE SODIUM at DailyMed |
Recent Clinical Trials for RABEPRAZOLE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
TenNor Therapeutics (Suzhou) Limited | Phase 3 |
Xuanzhu Biopharmaceutical Co., Ltd. | Phase 2 |
Boehringer Ingelheim | Phase 1 |
Pharmacology for RABEPRAZOLE SODIUM
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Medical Subject Heading (MeSH) Categories for RABEPRAZOLE SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for RABEPRAZOLE SODIUM
US Patents and Regulatory Information for RABEPRAZOLE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkem Labs Ltd | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 208644-001 | Apr 24, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mylan | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 076885-001 | Nov 8, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 076824-001 | Nov 8, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rubicon | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 204237-001 | Nov 18, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amneal Pharms | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 204179-001 | Jul 31, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aurobindo Pharma | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 205761-001 | Feb 17, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |